Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$120,000.00

Partnering with Patients to Strengthen the Evidence Base for Effectively Communicating Health Research Results to Study Participants and Others with Relevant Lived Experience

FY 2024-25

Summary
What is my research about? I aim to conduct three studies related to improving ways to communicate research results to patients. Why is it important? Sharing research results with patients in a clear and accessible way can help build trust in science and empower patients. Yet, most researchers do not communicate results with patients, and many say this is because they do not know how to simplify complex research concepts. What is my research plan? My research has three parts. (1) I will conduct a regularly updated review of trials that have compared different tools for communicating research results with patients (e.g., infographics, podcasts, videos, websites). This will help researchers identify the most effective tools for different groups. (2) I will conduct a trial comparing two common tools for communicating research, an infographic and a lay summary. This trial will be part of a larger series of trials that will be done among over 1,500 people enrolled in an established international cohort of people with the autoimmune disease scleroderma. Participants will be randomly assigned to receive either the infographic or the lay summary and will rate understandability, completeness of information, and ease of use. (3) I will conduct another trial to test if co-presentation of research by patients and researchers is more effective than traditional researcher-only presentations. This trial will take place during a virtual Scleroderma Research Day, where I will randomize attendees into one of two virtual rooms, researcher-only presentations or co-presentations by patients and researchers. Attendees will then rate presentations. Who is involved? A diverse team of 12 people with scleroderma and international experts in knowledge translation co-developed my research approach and will be actively involved. What is expected from my research? My work will help guide researchers to effectively communicate research results to patients and members of the public.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
518899
Name
Nassar Elsa-Lynn
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Partnering with Patients to Strengthen the Evidence Base for Effectively Communicating Health Research Results to Study Participants and Others with Relevant Lived Experience
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Clinical Trials; Cohort-Based Trials; Knowledge Dissemination; Knowledge Translation; Patient Communication; Patient Engagement; Patient-Partnered Research; Scleroderma; Systematic Review; Systemic Sclerosis
Abstract
What is my research about? I aim to conduct three studies related to improving ways to communicate research results to patients. Why is it important? Sharing research results with patients in a clear and accessible way can help build trust in science and empower patients. Yet, most researchers do not communicate results with patients, and many say this is because they do not know how to simplify complex research concepts. What is my research plan? My research has three parts. (1) I will conduct a regularly updated review of trials that have compared different tools for communicating research results with patients (e.g., infographics, podcasts, videos, websites). This will help researchers identify the most effective tools for different groups. (2) I will conduct a trial comparing two common tools for communicating research, an infographic and a lay summary. This trial will be part of a larger series of trials that will be done among over 1,500 people enrolled in an established international cohort of people with the autoimmune disease scleroderma. Participants will be randomly assigned to receive either the infographic or the lay summary and will rate understandability, completeness of information, and ease of use. (3) I will conduct another trial to test if co-presentation of research by patients and researchers is more effective than traditional researcher-only presentations. This trial will take place during a virtual Scleroderma Research Day, where I will randomize attendees into one of two virtual rooms, researcher-only presentations or co-presentations by patients and researchers. Attendees will then rate presentations. Who is involved? A diverse team of 12 people with scleroderma and international experts in knowledge translation co-developed my research approach and will be actively involved. What is expected from my research? My work will help guide researchers to effectively communicate research results to patients and members of the public.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Nassar, Elsa-Lynn
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
McGill University - $120,000 Grant (2024-25) | Canada Spends